Showing results (451-460 of 689) with videos related to

Sort By:
Pageof 69
Thrombosis and Haemostasis|May 4, 2018
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 TrialJames D Douketis, Sabina A Murphy, Elliott M Antman, et al.
The American Journal of Cardiology|December 13, 2000
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial InfarctionC M Gibson, M Anshelevich, S Murphy, et al.
JAMA|September 19, 2001
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3D A Morrow, E M Antman, L Parsons, et al.
Journal of the American College of Cardiology|March 14, 2020
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeBenjamin M Scirica, Brian A Bergmark, David A Morrow, et al.
Medicina|April 11, 2013
[Visceral leishmaniasis in Argentina. Cases notification and distribution of vectors (2006-2012)]Ignacio T Gould, Mónica S Perner, María S Santini, et al.
Clinical Chemistry|September 21, 2013
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromeErin A Bohula May, Marc P Bonaca, Petr Jarolim, et al.
The American Journal of Cardiology|October 15, 2003
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarctionJuhana Karha, Sabina A Murphy, Ajay J Kirtane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
Journal of the American College of Cardiology|August 18, 2004
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarctionStephen D Wiviott, David A Morrow, Paul D Frederick, et al.
The American Journal of Cardiology|January 27, 2005
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarctionHung Q Ly, Ajay J Kirtane, Jacki Buros, et al.
Pageof 69